RFEMB HOLDINGS LLC has a total of 37 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets medical technology, pharmaceuticals and biotechnology are METAVENTION INC, HOLAIRA INC and MCINTYRE JON T.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | United States | 6 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Republic of Korea | 3 | |
#6 | Australia | 2 | |
#7 | China | 2 | |
#8 | Chile | 1 | |
#9 | Dominican Republic | 1 | |
#10 | Hong Kong | 1 | |
#11 | Israel | 1 | |
#12 | Mexico | 1 | |
#13 | Philippines | 1 | |
#14 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Diagnosis and surgery | |
#2 | Electrotherapy | |
#3 | Syringes | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations | |
#6 | Peptides | |
#7 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Miessau James A | 28 |
#2 | Onik Gary M | 27 |
#3 | Bostwick David G | 17 |
#4 | Onik Gary | 7 |
#5 | Miessau Jim | 6 |
#6 | Bostwick Md Mba Dg | 5 |
#7 | James A Miessau | 2 |
#8 | Gary M Onik | 2 |
#9 | Bostwick Dg | 1 |
#10 | Gary M Onik M | 1 |
Publication | Filing date | Title |
---|---|---|
CN109069624A | The immunization therapy of cancer | |
US2018028264A1 | Radio-frequency electrical membrane breakdown for the treatment of cardiac rhythm disorders and for renal neuromodulation | |
US2018021084A1 | Radio-frequency electrical membrane breakdown for reducing restenosis | |
WO2016126778A1 | Radio-frequency electrical membrane breakdown for the treatment of benign prostatic hyperplasia | |
CA2975931A1 | Radio-frequency electrical membrane breakdown for the treatment of adipose tissue and removal of unwanted body fat | |
CA2975123A1 | Radio-frequency electrical membrane breakdown for the treatment of high risk and recurrent prostate cancer, unresectable pancreatic cancer, tumors of the breast, melanoma or otherskin malignancies, sarcoma, soft tissue tumors, ductal carcinoma, neoplasia, and intra and extra luminal abnormal tissue | |
EP3077041A1 | Cancer immunotherapy by radiofrequency electrical membrane breakdown (rf-emb) |